Skip To Main Content
Alla Feldbarg on Muck Rack

Alla Feldbarg

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Alla

Contact Alla, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

NMDA subunit 2B-selective negative allosteric modulator satoprodil (BI 1569912) as mono- and adjunctive therapy in patients with major depressive disorder: results from two phase 2 randomized, controlled trials

|
By Elan Cohen, Gerard Sanacora, Koichiro Watanabe, Rainer-Georg Goeldner, Andreas Scholz, Sigurd D. Süssmuth, Franco De Crescenzo, Alla Feldbarg, Brittney Starling, J. Corey Fowler
| Nature Verified
Abstract Major depressive disorder (MDD) is a leading cause of disability worldwide, with many patients experiencing inadequate response to standard antidepressants. Dysregulation of N-methyl-D-aspartate (NMDA) receptor activity is implicated in the pathophysiology of MDD.
Open in Who Shared Issue with article?
See all 1 articles